A Case Report of a Malignant Triton Tumor of the Left Retroperitoneum in a Young Female Without Neurofi bromatosis

<p>Malignant peripheral nerve sheath tumors (MPNST) are malignant cancers with origins found within peripheral nerves of various body regions-most commonly involving the buttocks, thighs, brachial plexus and para-spinal region [1]. While MPNSTs account for only 5%-10% of all soft tissue sarcom...

Full description

Saved in:
Bibliographic Details
Main Authors: Dayton Grogan BS (Author), Vamsi Reddy BS (Author), Earl Dane Jones (Author), Cargill H Alleyne (Author)
Format: Book
Published: Global Journal of Rare Diseases - Peertechz Publications, 2019-09-20.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 peertech__10_17352_2640-7876_000016
042 |a dc 
100 1 0 |a Dayton Grogan BS  |e author 
700 1 0 |a  Vamsi Reddy BS  |e author 
700 1 0 |a  Earl Dane Jones  |e author 
700 1 0 |a Cargill H Alleyne  |e author 
245 0 0 |a A Case Report of a Malignant Triton Tumor of the Left Retroperitoneum in a Young Female Without Neurofi bromatosis 
260 |b Global Journal of Rare Diseases - Peertechz Publications,   |c 2019-09-20. 
520 |a <p>Malignant peripheral nerve sheath tumors (MPNST) are malignant cancers with origins found within peripheral nerves of various body regions-most commonly involving the buttocks, thighs, brachial plexus and para-spinal region [1]. While MPNSTs account for only 5%-10% of all soft tissue sarcomas, there exist MPNST variations that occur with greater rarity [2]. Specifi cally, Malignant Triton Tumors (MTT) are a subset of MPNST with rhabdomyoblastic differentiation and account for only 5% of all MPNST cases [3]. MTTs were fi rst described by Mason in 1932 and found to occur in patients with Neurofi bromatosis type 1 (NF-1) in slightly more than 50% of cases. This is because sMTTs are believed to originate from Schwann cells of peripheral nerves or within existing neurofi bromas [3,4]. Diagnosis of MTT is confi rmed by immunohistochemical screening for desmin, vimentin, actin, myoglobulin, and S-100 protein.</p> 
540 |a Copyright © Dayton Grogan BS et al. 
546 |a en 
655 7 |a Case Report  |2 local 
856 4 1 |u https://doi.org/10.17352/2640-7876.000016  |z Connect to this object online.